BIVI 外汇新闻
BioVie Announces Positive Topline Results From Phase 2 Trial Of NE3107 To Treat Alzheimer's Disease
Clinical-stage company BioVie Inc. (BIVI) announced Wednesday topline results from an investigator-Sponsored Phase 2 clinical trial of NE3107 for the treatment of Alzheimer's Disease (AD).
RTTNews
|
858天前
